IRTC
iRhythm Technologies, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$123.07
−0.29%Year over year
Reported trailing growth
- Revenue
- +25.6%
- EBITDA
- +138.5%
- EBIT
- +90.5%
- EPS
- +85.3%
- Free cash flow
- +39.8%
- Operating cash flow
- +35.8%
Forward estimates
Based on analyst estimates
- Revenue
- +16.6%
- EBITDA
- +243.1%
- EPS
- +216.1%
Three-year CAGR
- Revenue
- +22.1%
- EBITDA
- +94.7%
- EBIT
- +68.1%
- Net income
- +60.7%
- EPS
- +61.7%
- Free cash flow
- +175.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026